Pharmafile Logo
Pharmafocus logo
Advanced Search
uk_china_flags_half_and_half

UK and China sign £2 billion in healthcare trade and investment deals

October 22, 2015
Research and Development

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …

News
pi

Physicians Interactive acquires Univadis portal

October 22, 2015
Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …

News
mgt_kingsley

Executive vice president Tony Kingsley leaves Biogen

October 22, 2015
Biogen, John Cox, Tony Kingsley

Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …

Appointment
Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015
Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

News
Aspirin

World’s largest clinical trial of aspirin in cancer launches in UK

October 22, 2015
Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …

News
biogen_logo

Revenues up at Biogen – but job losses planned

October 22, 2015
Biogen, financial results, job losses, redundancies

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

News
Biogen image

Biogen’s natalizumab fails Phase III endpoints

October 21, 2015
Biogen, multiple sclerosis

Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …

News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015
Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …

News
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

Appointment
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

News
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015
Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …

Feature

Global warning for governments to step up R&D spending

October 21, 2015
Research and Development

Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …

News
Ezetrol

NICE issues draft guidance for MSD’s Ezetrol

October 21, 2015
Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol

NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol.  The guidance updates …

News
Humira

Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015
Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …

Feature
novartis_pic

Novartis acquires Admune Therapeutics

October 21, 2015
Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy

Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …

News
nhs_sign

NHS research activity on the rise

October 21, 2015
Research and Development

NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …

News
Valeant logo

Valeant announces strong Q3 results, will expand US contact lens plant

October 20, 2015
Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production

Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …

News
Sprout sign

‘Female Viagra’ goes on sale in the US

October 20, 2015
Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder

The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …

News
Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015
Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026